Asahi Of Japan Wins $547 Million U.S. Jury Award Against Actelion
This article was originally published in PharmAsia News
Executive Summary
Japan's Asahi Kasei Pharma won a $547 million jury award in a U.S. state court against Swiss-based Actelion over a development agreement between the firms more than three years ago